P&G Hygiene and Health Care Limited has notified shareholders about the Securities and Exchange Board of India's (SEBI) extended special window for transfer and dematerialization of physical securities. The company made this disclosure on April 7, 2026, informing eligible shareholders about the opportunity to re-lodge transfer requests that were previously rejected or not processed.

SEBI Special Window Details

The notification relates to SEBI circular HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026, regarding "Ease of Doing Investment – Special Window for Re-lodgement of Transfer Requests of Physical Shares." The regulatory body has extended the timeline for a special window exclusively for re-lodgement of transfer deeds that were originally lodged prior to April 1, 2019.

Eligibility and Process

The special window is available for transfer requests that were rejected, returned, or not attended to due to deficiencies in documents, processes, or other issues. All securities re-lodged for transfer during this window will be processed only in dematerialized form, as per SEBI guidelines.

Shareholders can submit their transfer requests along with requisite documents to the company's Registrar and Share Transfer Agent (RTA) at MUFG Intime India Pvt. Ltd. (formerly Link Intime India Pvt. Ltd.), located at C-101, Embassy 247, L.B.S. Marg Vikhroli (West), Mumbai-400083, or via email at investor.helpdesk@in.mps.mufg.com .

Corporate Compliance

The disclosure was signed by Ghanashyam Hegde, Executive Director and Company Secretary (DIN: 08054712), as part of the company's regulatory compliance obligations. P&G Hygiene and Health Care Limited operates with CIN L42439MH1964PLC012971 and maintains its registered office at P&G Plaza, Cardinal Gracias Road, Chakala, Andheri (E), Mumbai 400099.

P&G Hygiene and Health Care has announced a crucial board meeting scheduled for May 28, 2026, where directors will review the company's annual financial performance and consider dividend distribution to shareholders. The meeting represents a key milestone in the company's corporate calendar as it marks the formal approval of year-end financial results.

Board Meeting Agenda and Key Decisions

The board meeting has been convened primarily to address two critical corporate matters that directly impact shareholders and stakeholders. The directors will focus on reviewing the company's financial performance for the completed fiscal year and making important decisions regarding shareholder returns.

Financial Statements Review Process

The primary agenda item involves the consideration and approval of audited financial statements for the financial year ending March 31, 2026. This process represents the culmination of the company's annual financial reporting cycle, where the board will examine the comprehensive financial performance, including revenue, profitability, and overall business health. The audited statements provide stakeholders with verified financial information that has undergone rigorous external scrutiny.

Dividend Deliberations

Alongside the financial statements approval, the board will consider the recommendation of a final dividend for shareholders. This decision reflects the company's commitment to sharing profits with its investor base and demonstrates confidence in its financial position. The final dividend consideration follows standard corporate practices where companies evaluate their cash flows, future capital requirements, and overall financial health before making distribution decisions.

Regulatory Compliance and Transparency

The announcement was made in strict compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory framework ensures that listed companies maintain transparency with their stakeholders by providing advance notice of significant board meetings. The company has fulfilled its obligation to inform both the BSE Limited and the National Stock Exchange of India Limited about the scheduled meeting, demonstrating adherence to corporate governance standards.

Corporate Communication Framework

Procter & Gamble Hygiene and Health Care Limited has maintained its commitment to transparent communication with regulatory authorities and shareholders. The formal notification was signed by Flavia Machado, an authorized signatory, and submitted to both major stock exchanges where the company's shares are listed. This systematic approach to corporate communication ensures that all stakeholders receive timely information about significant corporate developments that may impact their investment decisions.